Alnylam Pharmaceuticals
ALNY
#446
Rank
HK$408.82 B
Marketcap
HK$3,094
Share price
-3.65%
Change (1 day)
56.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company